Clinical Trial Update: Safety and Effects of Using Prime-boost HIVIS DNA and MVA-CMDR Vaccine Regimens With or Without Toll-like Receptor 4 Agonist on HIV Reservoirs in Perinatally HIV Infected Children and Youth [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and effects of prime-boost HIVIS DNA and MVA-CMDR vaccines, with or without a Toll-like receptor 4 agonist, in perinatally HIV-i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HIVIS DNA
• MVA-CMDR vaccine
• Toll-like receptor 4 agonist

Snippet

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine | Conditions: HIV Infections | Phase 1 | Status: COMPLETED